235 related articles for article (PubMed ID: 15158789)
1. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Miri R; Knaus EE
Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Vo D; Velázquez C; Knaus EE
Bioorg Med Chem; 2005 Jun; 13(12):4085-91. PubMed ID: 15911322
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4-pyridyl and 3-arylethyloxycarbonyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1990 Dec; 7(1):11-7. PubMed ID: 2096831
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of pharmacological activities of 3, 5-dialkyl 1, 4-dihydro-2,6-dimethyl-4-nitroimidazole-3, 5-pyridine dicarboxylates.
Miri R; Javidnia K; Kebriaie-Zadeh A; Niknahad H; Shaygani N; Semnanian S; Shafiee A
Arch Pharm (Weinheim); 2003 Sep; 336(9):422-8. PubMed ID: 14528490
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
Navidpour L; Miri R; Shafiee A
Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and calcium channel antagonist activity of alkyl cycloalkyl esters of nifedipine containing pyridinyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1989 Dec; 5(2):117-23. PubMed ID: 2577981
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and calcium channel antagonist activity of alkyl t-butyl esters of nifedipine analogues containing pyridinyl substituents.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1987 Dec; 2(2):79-89. PubMed ID: 2855571
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
